Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 7.

Goldkuhle, Marius, Bender, Ralf, Akl, Elie A., van Dalen, Elvira C., Nevitt, Sarah, Mustafa, Reem A., Guyatt, Gordon H., Trivella, Marialene, Djulbegovic, Benjamin, Schunemann, Holger, Cinquini, Michela, Kreuzberger, Nina ORCID: 0000-0001-8922-0488 and Skoetz, Nicole (2021). GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes-Study limitations due to censoring of participants with missing data in intervention studies. J. Clin. Epidemiol., 129. S. 126 - 138. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-5921

Peinemann, Frank ORCID: 0000-0002-4727-1313, Tushabe, Doreen A., van Dalen, Elvira C. and Berthold, Frank (2015). Rapid COJEC versus standard induction therapies for high-risk neuroblastoma. Cochrane Database Syst Rev. (5). HOBOKEN: WILEY. ISSN 1361-6137

Peinemann, Frank, van Dalen, Elvira C., Enk, Heike and Berthold, Frank (2017). Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. Cochrane Database Syst Rev. (8). HOBOKEN: WILEY. ISSN 1361-6137

Peinemann, Frank, van Dalen, Elvira C., Enk, Heike and Tytgat, Godelieve A. M. (2019). Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation. Cochrane Database Syst Rev. (4). HOBOKEN: WILEY. ISSN 1361-6137

Peinemann, Frank ORCID: 0000-0002-4727-1313, van Dalen, Elvira C., Tushabe, Doreen A. and Berthold, Frank (2015). Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation. Cochrane Database Syst Rev. (1). HOBOKEN: WILEY. ISSN 1361-6137

Skoetz, Nicole, Goldkuhle, Marius, Weigl, Aaron, Dwan, Kerry, Labonte, Valerie, Dahm, Philipp ORCID: 0000-0003-2819-2553, Meerpohl, Joerg J., Djulbegovic, Benjamin and van Dalen, Elvira C. (2019). Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviews. J. Clin. Epidemiol., 108. S. 1 - 10. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-5921

Skoetz, Nicole, Goldkuhle, Marius, van Dalen, Elvira C., Akl, Elie A., Trivella, Marialena, Mustafa, Reem A., Nowak, Artur, Dahm, Philipp, Schunemann, Holger and Bender, Ralf (2020). GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and Evidence Profiles. J. Clin. Epidemiol., 118. S. 124 - 132. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1878-5921

This list was generated on Sat Apr 27 02:11:59 2024 CEST.